| Literature DB >> 29747623 |
Na-Hui Kim1, Sihan Song2, So-Youn Jung3, Eunsook Lee3, Zisun Kim4, Hyeong-Gon Moon5,6, Dong-Young Noh5,6, Jung Eun Lee7.
Abstract
BACKGROUND: There is limited evidence for the association between dietary pattern and quality of life among breast cancer survivors. We examined the association between dietary patterns and health-related quality of life (HRQoL) among Korean breast cancer survivors.Entities:
Keywords: Breast cancer; Breast cancer survivors; Dietary patterns; Health-related quality of life
Mesh:
Year: 2018 PMID: 29747623 PMCID: PMC5946513 DOI: 10.1186/s12905-018-0555-7
Source DB: PubMed Journal: BMC Womens Health ISSN: 1472-6874 Impact factor: 2.809
Rotated factor loadingsa for dietary patterns identified by factor analysis in the breast cancer survivors
| Food or food group | Pattern 1 | Pattern 2 |
|---|---|---|
| Vegetables | 0.6432 | . |
| Whole grains | 0.6174 | . |
| Soy | 0.4563 | . |
| Potatoes | 0.3642 | . |
| Fish | 0.3637 | . |
| Fruits | 0.3302 | −0.3071 |
| Yogurt | 0.3151 | . |
| Kimchi | 0.3120 | . |
| Mushrooms | 0.2807 | . |
| Milk | . | . |
| Other seafood | . | . |
| Salted seafood | . | . |
| Rice soup | . | . |
| Rice cake | . | . |
| Cakes/snacks | −0.2021 | . |
| Alcoholic drinks | −0.2114 | . |
| Pork | −0.2318 | . |
| Rice rolls | −0.2371 | . |
| Ice cream | −0.2506 | . |
| Beverages | −0.2962 | . |
| Hamburgers/pizza | −0.3035 | . |
| Noodles | −0.3059 | . |
| Refined grains | −0.3761 | . |
| Coffee | −0.4113 | . |
| Salad | . | 0.6423 |
| Seasonings | 0.2921 | 0.5166 |
| Dressings | 0.2023 | 0.4742 |
| Mixed rice | . | 0.4170 |
| Pancakes | . | 0.3199 |
| Eggs | 0.2121 | 0.3016 |
| Processed seafood | . | 0.2757 |
| Chicken/duck meat | . | 0.2382 |
| Beef | . | 0.2236 |
| Vegetable oil | . | . |
| Tea | . | . |
| Chocolate/sugar | . | . |
| Vegetable or fruit juice | . | . |
| Nuts | . | −0.2004 |
| Seaweed | . | −0.2354 |
aAbsolute values greater than 0.2 were presented
Characteristics of participants according to quartiles of the Healthy and Western dietary pattern
| Quartiles of Healthy dietary pattern | Quartiles of Western dietary pattern | |||||||
|---|---|---|---|---|---|---|---|---|
| Variables | Quartile 1 ( | Quartile 2 ( | Quartile 3 ( | Quartile 4 ( | Quartile 1 ( | Quartile 2 ( | Quartile 3 ( | Quartile 4 ( |
| Age at diagnosis (years), mean(SD) | 44.98 (7.51) | 47.22 (8.07) | 50.21 (8.15) | 51.09 (8.42) | 49.71 (7.42) | 48.86 (7.34) | 49.38 (8.64) | 45.55 (9.38) |
| Body mass index at diagnosis (kg/m2), mean(SD) | 23.23 (3.10) | 23.21 (2.60) | 23.42 (2.63) | 22.72 (2.95) | 22.82 (2.47) | 23.16 (2.64) | 23.18 (2.88) | 23.41 (3.27) |
| Time since surgery (month), mean(SD) | 42.66 (37.26) | 32.48 (26.67) | 36.02 (31.13) | 28.25 (23.17) | 35.43 (27.84) | 34.30 (28.94) | 34.30 (30.79) | 35.38 (34.02) |
| Education levela, n(%) | ||||||||
| Elementary school | 1 (1.75) | 1 (1.75) | 5 (8.62) | 1 (1.79) | 5 (8.77) | 2 (3.57) | 1 (1.72) | 0 (0.00) |
| Middle school | 1 (1.75) | 2 (3.51) | 0 (0.00) | 7 (12.50) | 4 (7.02) | 2 (3.57) | 0 (0.00) | 4 (7.02) |
| High school | 24 (42.11) | 24 (42.11) | 31 (53.45) | 28 (50.00) | 23 (40.35) | 28 (50.00) | 32 (55.17) | 24 (42.11) |
| College or above | 31 (54.39) | 30 (52.63) | 22 (37.93) | 20 (35.71) | 25 (43.86) | 24 (42.86) | 25 (43.10) | 29 (50.88) |
| Marital status, n(%) | ||||||||
| Married or cohabitation | 49 (85.96) | 46 (80.70) | 51 (87.93) | 46 (80.70) | 49 (87.50) | 48 (82.76) | 50 (86.21) | 45 (78.95) |
| Unmarried, divorced, or Widowed | 8 (14.04) | 11 (19.30) | 7 (12.07) | 11 (19.30) | 7 (12.50) | 10 (17.24) | 8 (13.79) | 12 (21.05) |
| Physical activity (MET-hours/week), mean(SD) | 26.52 (29.64) | 37.38 (36.61) | 40.64 (43.39) | 40.47 (28.43) | 40.41 (39.80) | 40.72 (40.69) | 27.77 (21.80) | 36.10 (34.93) |
| Menopausal statusa, n(%) | ||||||||
| Pre-menopause | 26 (44.83) | 28 (48.28) | 19 (32.76) | 11 (18.97) | 17 (29.31) | 19 (32.76) | 23 (39.66) | 25 (43.10) |
| Post-menopause | 32 (55.17) | 30 (51.72) | 39 (67.24) | 47 (81.03) | 41 (70.69) | 39 (67.24) | 35 (60.34) | 33 (56.90) |
| Smoking statusa, n(%) | ||||||||
| Never | 49 (92.45) | 50 (98.04) | 54 (98.18) | 49 (96.08) | 46 (97.87) | 51 (100.00) | 54 (94.74) | 51 (92.73) |
| Ever | 4 (7.55) | 1 (1.96) | 1 (1.82) | 2 (3.92) | 1 (2.13) | 0 (0.00) | 3 (5.26) | 4 (7.27) |
| Alcohol intakea, n(%) | ||||||||
| Never | 23 (40.35) | 32 (56.14) | 30 (51.72) | 28 (49.12) | 31 (55.36) | 33 (56.90) | 29 (50.00) | 20 (35.09) |
| Past | 20 (35.09) | 18 (31.58) | 25 (43.10) | 25 (43.86) | 21 (37.50) | 20 (34.48) | 22 (37.93) | 25 (43.86) |
| Current | 14 (24.56) | 7 (12.28) | 3 (5.17) | 4 (7.02) | 4 (7.14) | 5 (8.62) | 7 (12.07) | 12 (21.05) |
| AJCC stage at diagnosis, n(%) | ||||||||
| I | 27 (46.55) | 24 (41.38) | 29 (50.00) | 23 (39.66) | 25 (43.10) | 25 (43.10) | 25 (43.10) | 28 (48.28) |
| II | 24 (41.38) | 27 (46.55) | 18 (31.03) | 30 (51.72) | 25 (43.10) | 26 (44.83) | 24 (41.38) | 24 (41.38) |
| III | 7 (12.07) | 7 (12.07) | 11 (18.97) | 5 (8.62) | 8 (13.79) | 7 (12.07) | 9 (15.52) | 6 (10.34) |
| Energy intake (kcal/day), mean(SD) | 1659.13 (358.84) | 1679.76 (347.61) | 1719.96 (372.85) | 2049.69 (376.88) | 1735.57 (351.47) | 1648.52 (353.61) | 1796.81 (412.43) | 1927.63 (415.55) |
| Dietary supplement usea,b, n(%) | ||||||||
| No | 15 (25.86) | 18 (32.14) | 19 (32.76) | 17 (30.36) | 14 (24.14) | 19 (33.33) | 20 (35.09) | 16 (28.57) |
| Yes | 43 (74.14) | 38 (67.86) | 39 (67.24) | 39 (69.64) | 44 (75.86) | 38 (66.67) | 37 (64.91) | 40 (71.43) |
SD standard deviation, AJCC American joint committee on cancer, MET metabolic equivalent of task
Median months since surgery (25th, 75th percentiles) was 23.77 (15.22, 46.27) months
aMissing value are not shown
bBoth nutrient supplement and health functional food were considered
Least squares (LS) means scoresa (95% Confidence intervals, CIs) of HRQoL according to quartiles of Healthy dietary pattern in breast cancer survivors
| Quartiles of the Healthy dietary pattern | ||||||
|---|---|---|---|---|---|---|
| Variables | Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | ||
| EORTC QLQ - C30 | ||||||
| Global health status/QoL | 220 | 40.41 (28.37 - 57.55) | 37.47 (27.10 - 51.81) | 39.93 (28.92 - 55.14) | 30.00 (20.83 - 43.21) | 0.31 |
| Functioning | ||||||
| Physical Functioning | 228 | 76.21 (67.82 - 85.65) | 79.02 (71.09 - 87.85) | 77.80 (69.85 - 86.65) | 71.45 (63.52 - 80.37) | 0.45 |
| Role Functioning | 229 | 62.82 (49.32 - 80.02) | 77.50 (61.80- 97.17) | 69.47 (55.05 - 87.66) | 65.77 (51.12 - 84.62) | 0.84 |
| Emotional Functioning | 230 | 76.24 (63.16 - 92.04) | 72.09 (60.45 - 85.96) | 60.42 (50.51 - 72.26) | 71.77 (58.99 - 87.32) | 0.31 |
| Cognitive Functioning | 230 | 74.53 (65.00 - 85.44) | 78.52 (69.10 - 89.22) | 73.09 (64.18 - 83.23) | 70.66 (61.28 - 81.47) | 0.48 |
| Social Functioning | 230 | 57.8 (45.69 - 73.12) | 63.28 (50.80 - 78.84) | 60.55 (48.42 - 75.72) | 62.67 (49.05 - 80.05) | 0.66 |
| Symptom | ||||||
| Fatigue | 229 | 27.26 (19.48 - 38.15) | 20.26 (14.88 - 27.58) | 22.61 (16.52 - 30.94) | 23.51 (16.68 - 33.13) | 0.55 |
| Nausea and vomiting | 230 | 4.00 (2.48 - 6.44) | 2.24 (1.44 - 3.49) | 3.71 (2.36 - 5.83) | 3.17 (1.93 - 5.21) | 0.73 |
| Pain | 229 | 9.84 (5.80 - 16.71) | 6.13 (3.77 - 9.97) | 11.13 (6.79 - 18.24) | 10.64 (6.20 - 18.28) | 0.53 |
| Dyspneab,c | 228 | 8.86 (5.05 - 15.52) | 4.21 (2.52 - 7.03) | 4.75 (2.82 - 8.01) | 2.87 (1.62 - 5.08) | 0.005 |
| Insomniab,c | 228 | 11.46 (6.59 - 19.95) | 12.11 (7.28 - 20.15) | 20.41 (12.15 - 34.26) | 29.77 (16.87 - 52.51) | 0.005 |
| Loss of appetite | 228 | 3.00 (1.74 - 5.15) | 3.66 (2.23 - 6.02) | 2.65 (1.60 - 4.39) | 3.32 (1.91 - 5.79) | 0.99 |
| Constipation | 228 | 4.25 (2.40 - 7.54) | 5.69 (3.36 - 9.63) | 7.01 (4.10 - 11.99) | 4.18 (2.32 - 7.50) | 0.78 |
| Diarrhea | 230 | 3.04 (1.82 - 5.08) | 2.47 (1.53 - 3.99) | 2.76 (1.70 - 4.51) | 1.79 (1.05 - 3.05) | 0.18 |
| Financial impact | 230 | 7.34 (4.12 - 13.07) | 4.51 (2.63 - 7.74) | 9.47 (5.47 - 16.40) | 9.61 (5.27 - 17.53) | 0.27 |
| EORTC QLQ-BR23 | ||||||
| Functioning | ||||||
| Body image | 229 | 40.11 (27.32 - 58.88) | 33.23 (23.21 - 47.59) | 40.56 (28.06 - 58.62) | 28.18 (18.89 - 42.03) | 0.30 |
| Sexual functioning | 216 | 2.83 (1.62 - 4.92) | 3.89 (2.32 - 6.52) | 3.93 (2.33 - 6.65) | 3.94 (2.20 - 7.08) | 0.33 |
| Future perspective | 229 | 26.93 (15.91 - 45.58) | 20.85 (12.74 - 34.10) | 21.67 (13.08 - 35.90) | 15.43 (8.92 - 26.70) | 0.14 |
| Symptom | ||||||
| Systematic therapy side effects | 230 | 23.34 (17.37 - 31.37) | 15.01 (11.39 - 19.79) | 22.47 (16.96 - 29.76) | 25.97 (19.09 - 35.33) | 0.39 |
| Breast symptoms | 230 | 12.10 (7.66 - 19.11) | 6.96 (4.54 - 10.68) | 10.50 (6.80 - 16.22) | 12.11 (7.52 - 19.49) | 0.84 |
| Arm symptoms | 230 | 20.54 (13.59 - 31.03) | 18.25 (12.41 - 26.84) | 21.70 (14.65 - 32.12) | 31.48 (20.48 - 48.39) | 0.13 |
| Upset by hair loss | 151 | 14.15 (6.70 - 29.89) | 32.78 (15.61 - 68.82) | 23.84 (12.30 - 46.18) | 34.49 (16.45 - 72.32) | 0.11 |
LS means least squares means, 95% CI 95% confidence interval, HRQoL health-related quality of life, EORTC QLQ-C30 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, BR23 breast cancer module 23
aAdjusted for age at diagnosis (year; continuous), body mass index at diagnosis (kg/m2; continuous), energy intake (kcal/d; continuous), marital status (married or cohabitation, others), education level (high school or below, college or above), physical activity (MET-hr/wk.; continuous), breast cancer stage at diagnosis (I,II,III), time since surgery (months; continuous) and menopausal status at diagnosis (premenopausal, postmenopausal status)
bP value for comparing top with bottom quintiles < 0.05
cFalse Discovery Rate (FDR) < 0.1
Least squares (LS) means scoresa (95% Confidence intervals, CIs) of HRQoL according to quartiles of Western dietary pattern in breast cancer survivors
| Quartiles of Western dietary pattern | ||||||
|---|---|---|---|---|---|---|
| Variables | Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | ||
| EORTC QLQ - C30 | ||||||
| Global health status/QoL | 200 | 33.35 (23.82 - 46.70) | 36.10 (25.92 - 50.27) | 34.29 (24.56 - 47.89) | 43.52 (31.43 - 60.25) | 0.22 |
| Functioning | ||||||
| Physical Functioning | 228 | 67.65 (60.64 - 75.46) | 77.67 (69.77 - 86.45) | 81.89 (73.67 - 91.03) | 77.41 (69.47 - 86.24) | 0.06 |
| Role Functioning | 229 | 57.02 (45.20 - 71.93) | 70.04 (55.73 - 88.02) | 79.94 (63.68 - 100.34) | 70.20 (55.45 - 88.88) | 0.15 |
| Emotional Functioning | 230 | 63.32 (52.75 – 76.00) | 70.77 (59.14 - 84.69) | 77.86 (65.12 - 93.10) | 66.73 (55.55 - 80.15) | 0.61 |
| Cognitive Functioning | 230 | 74.49 (65.26 - 85.03) | 70.71 (62.09 - 80.53) | 78.88 (69.30 - 89.78) | 73.62 (64.47 - 84.06) | 0.86 |
| Social Functioning | 230 | 62.80 (50.07 - 78.78) | 61.88 (49.52 - 77.32) | 66.70 (53.43 - 83.26) | 53.96 (42.98 - 67.73) | 0.34 |
| Symptom | ||||||
| Fatigue | 229 | 25.62 (18.52 - 35.43) | 20.78 (15.17 - 28.46) | 22.48 (16.42 - 30.77) | 23.91 (17.34 - 32.96) | 0.88 |
| Nausea and vomiting | 230 | 4.96 (3.15 - 7.82) | 2.53 (1.62 - 3.95) | 2.17 (1.39 - 3.39) | 3.84 (2.43 - 6.06) | 0.46 |
| Pain | 229 | 12.87 (7.72 - 21.45) | 8.12 (4.94 - 13.33) | 8.19 (4.99 - 13.44) | 8.22 (4.95 - 13.63) | 0.21 |
| Dyspnea | 228 | 4.23 (2.45 - 7.30) | 6.61 (3.89 - 11.22) | 3.76 (2.21 - 6.39) | 4.50 (2.62 - 7.73) | 0.78 |
| Insomnia | 228 | 24.84 (14.51 - 42.52) | 11.00 (6.52 - 18.55) | 16.76 (9.96 - 28.19) | 18.81 (11.04 - 32.05) | 0.75 |
| Loss of appetite | 228 | 3.33 (1.98 - 5.61) | 3.08 (1.85 - 5.11) | 2.64 (1.59 - 4.37) | 3.65 (2.18 - 6.13) | 0.83 |
| Constipation | 228 | 4.44 (2.56 - 7.70) | 4.46 (2.61 - 7.60) | 4.67 (2.74 - 7.96) | 8.09 (4.69 - 13.94) | 0.07 |
| Diarrhea | 230 | 2.46 (1.50 - 4.04) | 1.9 (1.17 - 3.10) | 3.28 (2.02 - 5.33) | 2.47 (1.50 - 4.06) | 0.67 |
| Financial impact | 230 | 9.92 (5.65 - 17.43) | 6.97 (4.01 - 12.14) | 6.45 (3.72 - 11.20) | 6.42 (3.65 - 11.3) | 0.24 |
| EORTC QLQ-BR23 | ||||||
| Functioning | ||||||
| Body image | 229 | 38.50 (26.43 - 56.06) | 30.60 (21.23 - 44.12) | 41.82 (29.06 - 60.19) | 31.51 (21.69 - 45.77) | 0.62 |
| Sexual functioning | 216 | 4.15 (2.46 – 7.00) | 2.23 (1.32 - 3.76) | 4.77 (2.81 - 8.08) | 4.08 (2.40 - 6.93) | 0.55 |
| Future perspective | 229 | 18.36 (10.99 - 30.67) | 22.97 (13.94 - 37.85) | 28.15 (17.13 - 46.27) | 15.63 (9.39 - 26.03) | 0.64 |
| Symptom | ||||||
| Systematic therapy side effects | 230 | 24.90 (18.63 - 33.29) | 19.03 (14.31 - 25.32) | 18.20 (13.69 - 24.18) | 22.45 (16.78 - 30.04) | 0.65 |
| Breast symptoms | 230 | 16.03 (10.35 - 24.83) | 7.07 (4.60 - 10.87) | 8.36 (5.45 - 12.82) | 10.97 (7.07 - 17.01) | 0.35 |
| Arm symptoms | 230 | 27.23 (18.22 - 40.71) | 21.05 (14.18 - 31.25) | 20.81 (14.04 - 30.85) | 20.65 (13.8 - 30.91) | 0.32 |
| Upset by hair loss | 151 | 24.94 (12.52 - 49.66) | 29.96 (14.49 - 61.98) | 34.18 (16.69 – 70.00) | 17.16 (8.42 - 34.97) | 0.44 |
LS means least squares means, 95% CI 95% confidence interval, HRQoL health-related quality of life, EORTC QLQ- C30 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, BR23 breast cancer module 23
aAdjusted for age at diagnosis (year; continuous), body mass index at diagnosis (kg/m2; continuous), energy intake (kcal/d; continuous), marital status (married or cohabitation, others), education level (high school or below, college or above), physical activity (MET-hr/wk.; continuous), breast cancer stage at diagnosis (I,II,III), time since surgery (months; continuous) and menopausal status at diagnosis (premenopausal, postmenopausal status)